OPGx-NMNAT1

N/A

Report date: 2024/10/28 09:28:24

Base Information

Drug NameOPGx-NMNAT1
Drug Alias NameOPGx-NMNAT1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 gene transference
TargetsNicotinamide/nicotinic acid mononucleotide adenylyltransferase 1
Therapy Area/IndicationsRetinal Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOpus Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesN/A
Active IndicationsRetinal Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A